Mikhail V. Semënov
Neurobiology Program
Children's Hospital Boston
61 Binmney Street
Boston
USA
Name/email consistency: high
- LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. Semenov, M.V., He, X. J. Biol. Chem. (2006)
- SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. Semënov, M., Tamai, K., He, X. J. Biol. Chem. (2005)









